Ashwagandha

Ashwagandha is the 'King' of Ayurveda, the most well touted herb of all. Commonly seen as a pro-virility herb and especially effective in men, Ashwagandha holds anti-cancer, anti-inflammatory, and pro-fertility agents. Anxiety reducer synergistic with Alcohol.

This page features 95 unique references to scientific papers.

   
Looking to buy Ashwagandha? Buy from Amazon.com
  Why the buy link?


Follow this Page for updates

Also Known As

Withania Somnifera, Indian Ginseng, Winter Cherry, Dunal, Solanaceae


Do Not Confuse With

Withania coagulans (Different Plant)


Is a Form of


Goes Well With

  • Itself (Withanone reduces Withaferin-A induced cytotoxicity)

Caution Notice

Examine.com Medical Disclaimer

Limited human studies use 2-5g of Ashwagandha root powder daily, with the lower range for general vitality and the higher range for libido and vitality. This is similar to traditional usage of Ashwagandha root extract in Ayurveda.

Concentrated (X:1 extract) capsules can also be used, using the Withanolide and Withanoside content as a marker of purity.


Looking to buy Ashwagandha? Buy from Amazon.com or BodyBuilding.com
The Human Effect Matrix looks at human studies (excluding animal/petri-dish studies) to tell you what effect Ashwagandha has in your body, and how strong these effects are.
GradeLevel of Evidence
ARobust research conducted with repeated double blind clinical trials
BMultiple studies where at least two are double-blind and placebo controlled
CSingle double blind study or multiple cohort studies
DUncontrolled or observational studies only
Level of Evidence
EffectChange
Magnitude of Effect Size
Scientific ConsensusComments
CSperm Quality

Minor

Appears to enhance seminal quality, needs more studies against comparators

CTestosterone

Minor

Was effective in infertile men, may not be effective in increasing testosterone in otherwise healthy men.

CFollicle-Stimulating Hormone

Minor

Not overly notable, but a decrease has reached statistical significance

CLuteinizing Hormone

Minor

An increase in luteinizing hormone has been detected with ashwagandha supplementation.

CErections

Unable to aid psychogenic erectile dysfunction more than placebo

DImmunity

Minor

Minor T-cell activation following ingestion of Ashwagandha tinctures, needs to be replicated.

DNatural Killer Cell Activity

Minor

A slight increase in natural killer cell activity has been noted with ashwagandha supplementation.

DDiuresis

Minor

May have diuretic effects, although not to a remarkable degree.

DTotal Cholesterol

Minor

Decreases in total cholesterol have been seen due to ashwagandha ingestion.

DBlood glucose

Minor

A decrease in blood glucose has been noted with ashwagandha.

DLDL-C

Minor

A slight decrease in LDL-C has been noted following ashwagandha supplementation.

DTriglycerides

Minor

A slight decrease in triglycerides has been noted with ashwagandha.


Disagree? Join the Ashwagandha Discussion

Looking to buy Ashwagandha? Buy from Amazon.com or BodyBuilding.com
Table of Contents:


Edit1. Sources and Composition

1.1. Sources and Usage

Ashwagandha is a traditional Ayurvetic medicine from the plant Withania Somnifera and sometimes referred to as 'Indian Ginseng' or Wintercherry[1] and touted as the 'Queen of Ayurveda'.[2][3]

It is classified as an Adaptogen (compound able to reduce the biochemical effects of a perceived stress) and as a Rasayana, which is a term used to refer to the highest class of Ayurveda. It has been traditionally used to treat almost all forms of ailment[4] such as analgesia, astringent, adaptogen, anti-inflammatory, anti-stress, antispasmodic, anti-diabetes, immuno-stimulant and cardioprotective.[5][6] The root or root extract are commonly used, although the fruits of the Ashwagandha plant (the Wintercherries) also have therapeutic potential.

There has been reported to be high variability in the amount of active withanolides in common nutritional supplements,[7] which may be due either to lack of standardization of root powder.

1.2. Composition

  • The Withanolide series of steroidal lactones[8][9] usually referring to the withanolide A series[10][11], B[11], C[12], and D[11].
  • Withanosides 1-19, similar in structure to the alphabetical withanolides and typically numbered with roman numerals;[13] Withanoside II and IV tend to be seen as popular molecules
  • Related compounds Withoferin A (in the A series) and Withanone exist, sometimes also referred to as withanolide-like compounds[13]
  • Chlorinated Withanolides, or molecules with withanolide backbones and a chlorine molecule, such as chloronated Withaferin A molecules[14]
  • Sitoindosides (Glycowithanolides), also known as withanolide glycosides.[15][16]
  • Ashwagandhanolide[17] and Viscosa lactone B are sometimes referred to as Withanolides although not named after them.[13]
  • Beta-sitosterol and stigmaterol, as well as each molecule's glucoside.[18]
  • Flavonoids ranging from 15.5+/-1mg/g to 31.6+/-5.1mg/g[19]
  • Phenolic compounds such as Gallic Acid, Syringic Acid, Benzoic Acid, P-coumaric Acid, Vanillic Acid, Naringenin, Kaempferol, and Catechin; totalling around 17.8+/-5.8mg/g to 32.6+/-3.2mg/g dry weight with the most prominent one (Catechin) totalling near 13+/-8.9mg/g to 30.6+/-11.4mg/g[19]

Withanolides are present in all plants in the Solanaceae family of plants, of which Withania Somnifera(Ashwagandha) is the highest in concentrations.[9]

Unless otherwise standardized to a certain percentage, the amount of active Withanolide A (seen as the primary ingredient) and Withaferin-A are 1% of dry weight of the leaves (with negligible content in the roots) of Withania Somnifera.[20]

1.3. Structures

All the active withanosides share a backbone similar to testosterone, and vary depending on the configuration of the outer ring.[21]


Edit2. Inflammation and Immunity

2.1. Natural Killer Cells

Natural Killer (NK) Cells appear to have increased activity in persons who are both selected for low baseline NK cell activity, and who drink a polyherbal Ayurvetic tea containing Ashwagandha.[22] Increased NK cell activity has also been attributed to Ashwagandha in isolation, after 3-day consumption of 12mL Ashwagandha liquid format in otherwise healthy persons in a pilot study.[23]

2.2. Macrophages

In mice subject to stress (in this study, cold stress), Ashwagandha at 512.5mcg daily was able to increase phagocytosis by macrophages to near control levels although it was outperformed by beta-glucans from Maitake.[24]

2.3. Secondary to Neurology

At least one study has noted seemingly synergistic effects between Maitake (mushroom source of glucans) and Ashwagandha in stressed animals, as the reduction of perceived stress secondary to Ashwagandha's adaptogenic abilities itself reduced impairment of the immune system.[24] These effects were seen at a relatively low dose, at 512.5mcg daily in mice, and the expected rise of corticosterone seen with stressors is not seen with Ashwagandha preloading.[24]


Edit3. Cancer Metabolism

Ashwagandha has been demonstrated to possess cancer-selective cytoxicity (able to destroy tumor cells at concentrations that are non-toxic to regular cells) when it looks at either the Withiferin A content or an extract known as i-factor, which is Withanone.[3][25] Withiferin A had 4-fold higher cytotoxicity in cancer cells relative to contol, and Withanone as well as the i-extract (blend of nutraceuticals from Ashwagandha) appear to possess 33 to 38-fold higher cytotoxicity in cancer cells, with the extract being more potent.[3] Interestingly, the prescence of Withanone has been shown to be protective against Withaferin A induced toxicity in normal cells.[26]

Five canonical pathways seem to be implicated. p53 signalling, GM-CFS signaling, death receptor signaling, apoptosis signaling and G2-M DNA damage regulation pathway.[3][25] All fractions tested influenced p53 and had p53 involved in cytotoxicity, whereas only i-extract influenced G2-M.[3]

A later study suggested that cytotoxicity from Ashwagandha is mediated in the nucleus prior to the above signalling pathways mostly via the four genes TPX2, ING1, TFAP2A and LHX3; with three others less influential.[2] TPX2 is a protein regulator of Aurora-A (and this pathway seems to be regulated by withanone[27]), TFAP2A involved with Bcl-2 and SMAD signalling, LHX3 involved in cellular determination and oncogenesis, and ING1 (Inhibitor of Growth 1) both a determinator of cellular senscence as well as regulator of p53 signalling via acetylation and stablilization.[2][28] All of these genes seem to be influenced by oxidative stress, and thus anti-oxidant enzyme induction may mediate these effects.[2] Other explanations still exist, such as Withanone being able to prevent the sequestering of p53 in the nucleus from the pro-carcinogenic protein, mortalin.[29] This latter mechanism has been noted before to cause selective cancer cell killing.[30]

Ashwagandha appears to have a few different pathways of cytotoxicity in cancer cells, and interestingly can destroy cancer cells in preference to normal cells; not many studies have been done in vivo with animals or humans however, and the anti-cancer effects of Ashwagandha (and the active component in this regard, Withanone) is preliminary


Edit4. Longevity and Life Extension

4.1. General Longevity

Withanone, isolated from Ashwagandha, caused downregulation of p21WAF1 in non-cancerous human fibroblasts; a protein downstream of p53 involved in cellular senescence.[26][31] Withaferin-A was able to increase expression of p21WAF1 in isolation, but could not when co-incubated with Withanone.[26]

Fibroblasts treated with Withanone (2.5ug/mL) underwent 10-12 more population doublings than did control cells, correlated to a 20% increase in cellular lifespan; and were replicated in MRC5 cells (isolated from live lung culture).[26] This was hypothesized to be secondary to a decrease in cellular sensence, as there was approximately a 20% decrease in autofluorescence (indicative of cellular damage accumulation) and similar reductions in beta-galactosidase activity.[26]

4.2. Cytoprotection

Withanone has been demonstrated to increase cell viability (survival) when cells are insulted by either UV rays or by H2O2, although not to control levels.[26] Overall reductive capacity of a cell also appears to be increased (as evidenced by up to 40% increases in Glucose-6-phosphate dehydrogenase activity).[26]


Edit5. Interactions with Aesthetics

It was mentioned in the discussion of one study[26] that a trial of older men in India (50-59 years) given 3g Ashwagandha daily for a year enabled a greater amount of hair melanin content to be preserved, which should theoretically preserve hair color to a degree. Mentioned in the text entitled Clinical applications of Ayurvedic and Chinese herbs: monographs for the western herbal practitioner, the study (Kuppurajan, K, et al; 1980) cannot be located online.


Edit6. Neurological Interactions

6.1. Alzheimer's Disease

Ashwagandha can beneficially influence Alzheimer's disease pathology indirectly via the liver tissue, increasing Low-density Lipoprotein related protein levels.[32] In middle-aged and older mice, 30 day treatment of Ashwagandha at 1g/kg bodyweight of an extract (containing 75% withanolides, 20% withanosides) was able to reduce beta-amyloid pigmentation in the cortex (77%) and hippocampus (78%) of middle-aged mice, and of aged mice (49% in cortex, 52% in hippocampus) and all tested groups saw reductions in beta-amyloid oligomers.[32] Ashwagandha does not affect amyloid precursor protein processing whatsoever, and the benefits seen due to a normalization of sLRP:RAGE (to be discussed). Neprilysins and sLRP are both increased after Ashwagandha ingestion, but inhibition of Neprilysin upregulation does not inhibit the therapeutic benefit.[32]

The mechanism was through upregulation of LDL-related protein (LRP) in the liver and increasing mRNA about 2-fold and increasing circulating levels, soluble LRP which sequesters beta-amyloid pigment tissue into systemic circulation and away from the brain.[33] Soluble LRP (sLRP) tends to be decreased in Alzheimer's Disease,[34] and an abnormal ratio of low sLRP to high RAGE (Receptor for Advanced Glycemic End Products) appears to contribute to Alzheimer's Pathology.[35]

Has been demonstrated to greatly benefit symptoms and pathology of Alzheimer's disease after oral administration, but a high dose of concentrated withanolides/withanosides was used in the animal study

Even without clearance of beta-amyloid pigmentation, Ashwagandha constituents (Withanoside IV and Sominone) can reduce neurodegeneration induced by this pigment[36] and possesses metabolites that may act as acetylcholinesterase inhibitors (Withalide A mostly, although others are implicated[37])[38] although the effects seem to be heterogenous across the brain; increasing acetylcholinesterase in the globus pallidus and decreasing activity in other areas of the basal forebrain nuclei[39] and other components may offer protection from toxins that work via acetylcholinesterase inhibition such as Propoxur.[40]

Cholinergic (M1) neurotransmission also appears to be enhanced[39] and some components of Ashwagandha may actually be mimetics and activate cholinergic (M1) neurotransmission.[41]

Has other properties that may confer some additional benefit to Alzheimer's disease, although more applied studies need to be done on the matter

6.2. Neuroprotection from oxidation

Ashwagandha root extract, as well as isolated Withanolide A, have been demonstrated to reduce excitotoxicity-induced memory loss by preserving (or otherwise upregulating) anti-oxidant enzymes in rats.[42] The reduction of NMDA receptor expression (seen during memory loss) was also significantly reversed with Ashwagandha[42] and has been traced back to preventing a degree of the abnormalities unto Hsp70 that glutamate excitotoxicity induces.[43]

Ashwagandha has been demonstrated to, after reserpine-induced toxicity resulting in tardive dyskinesia in mice, to dose-dependently reduce symptoms (orofacial) of tardive dyskinesia.[44] This reversal of symptoms has also been seen with haloperidol-induced dyskinesia[45] and both are suspected to benefit symptoms secondary to increased anti-oxidant enzyme expression.[44][45]

Parkinson's Disease has also been shown to have beneficial symptom reduction and increased circulating catecholamines, possibly secondary to an observed increase in the anti-oxidant enzymes catalase and glutathione peroxidase.[46][47] Huntington's disease has also shown benefit from the induction of these two enzymes, and established causation using 3-nitropropinoic acid as a research neurotoxin.[48] Along these lines, dopaminergic neurons are also protected via Ashwagandha during periods of morphine withdrawal;[49] which tend to be associated with significant localized atrophy in dopaminergic neurons.[49][50]

Cholinergic antagonists and induced memory loss (such as reserpine) have also been shown to have their effects reversed somewhat with Ashwagandha in vivo,[51] able to attenuate decreases in Brain-Derived Neurotrophic factor (BDNF) at 100mg/kg bodyweight intake of Withaferin-A/Withanone rich Ashwagandha extract, and increase BDNF levels above that of control at higher doses.[51]

It is possible that these inductions of anti-oxidant enzymes are secondary to induction of Heme-Oxygenase 1, which is from Ashwagandha acting on KEAP-1 to induce activation of Nrf2; however, this lead is one in vitro study with industry funding[52] and a PLoS entry[53] demonstrating that Ashwagandha (specifically, the isolated withanone) was able to inhibit premature oxidant-induced senescence of cells via inducing Nrf2 and the Anti-oxidant response element and keep levels of anti-oxidant enzymes fairly stable near control levels at 10uM.[53] This induction was greater than that recorded by Genistein, a soy isoflavone.

An underlying mechanism(s) related to the anti-oxidant enzymes appears to mediate protection from a variety of cognitive diseases associated with oxidative stress. This may be Nrf2 induction, which would suggest that the effects are similar to many other polyphenolic compounds

6.3. Neurogenesis

In mice treated with beta-amyloid (Aβ 25-35), the bioactive Withanoside IV (at 10umol/kg daily oral ingestion) via its in vivo metabolite Sominone was able to attenuate dendritic and synaptic reductions in the toxin-treated mice, while increasing axon and neuronal immunostaining (via NH-2) beyond that of control which indicates neurogenesis rather than merely preventing decline.[54] Although this in vivo study did not note dendritic immunostaining greater than control (possibly due to negative influences form Aβ 25-35), dendritic extension has been seen in human neuroblastoma cells at 5ug/mL (methanolic extract) attributed to the Withanolide A and Withanosides IV and VI content[55] although additional research suggests the latter two influence dendrites more and Withanolide A influencing axon length more and were able to elongate and potentiate dopaminergic neurons.[56] These results suggest Ashwagandha possesses both rehabilitative benefit and could also benefit those without cognitive impairment,[57] although applied studies have not yet been undergone in humans.

Appears to induce growth of dendrites and axons (parts of neurons) and appears to be active in mice after oral administration; may be a promising therapeutic or cognitive enhancement strategy

6.4. Obsession and Anxiety

Ashwagandha has been used effectively in reducing anxiety, depression, and parameters thereof in rats (biochemical, such as tribulin; experimental, such as social interaction) at 20-50mg/kg oral ingestion of the withanolide glycosides; this was comparable to 0.5mg/kg lorazepam (a benzodiazepine) for anxiety, and 10mg/kg imipramine (anti-depression).[58] The reduction in anxiety seen with Ashwagandha works synergistically with drinking Alcohol,[59] and appears to reduce the social anxiety associated with prolonged social isolation.[60]

When tested in humans at either 250mg daily (in two doses of 125mg at lunch and dinner) or 125mg (125mg at lunch, placebo at dinner) all standardized to 11.90% withanolide glycosides, 1.05% withaferin A, and 40.25% oligosaccharides with 3.44% polysaccharides[61] over 60 days in 98 persons (18-60) with chronic stress and without any other medication saw significant improvements over placebo in regards to 11 parameters of anxiety such as forgetfulness, feelings of impending doom, irritability, sleeplessness, fatigue, dry mouth, loss of hunger, headaches and muscle pain, and inability to concentrate.[62] Although the higher dose group (250mg) appeared to have more benefit than the lower dose group (125mg), the differences between the two were not clinically significant.[63]

Rat studies suggest that Ashwagandha is validated in its usage traditionally as an Anti-Hikkikomori herb (Mood stabilizer in social isolation)

At least one study has suggested that Withania Somnifera (Ashwagandha) can help with Obsessive-Compulsive Disorder.[64] Based on the assumption that Ashwagandha has traditionally been used to cure 'mood disturbances', a study was conducted on mouse marble-burying behaviour (an established research model for OCD[65]) and found that 10-100mg/kg bodyweight ethanolic extract of Withania Somnifera was able to reduce OCD-like symptoms; with 25 and 50mg/kg being seen as best, as 10mg/kg was statistically ineffective and 100mg/kg associated with sedation (the anti-OCD effects still held true, but sedation was suggestive of impairment and lowered internal validity somewhat).[64] Ashwagandha was about as effective at 10mg/kg as Fluoxetine at 5mg/kg bodyweight (both dosed too low to be significantly different than control) yet the combination of the two abolished OCD-like behaviour while pairing Ashwagandha with ritanserin (a serotonergic antagonist) negated the benefits of both; suggesting Ashwagandha benefits OCD via serotonergic mechanisms.[64]

6.5. Sedation and Sleep

Ashwagandha may have a GABA-ergic mechanism of action and benzodiazepine-like effects; two studies have been conducted in sleep-disturbed mice,[66][67] and both studies used 0.5mg diazepam (a benzodiazepine) as a comparative agent to 100-200mg/kg (injections) of Ashwagandha, and the effects on sleep latency, slow wave and REM sleep, as well as total waking and sleeping time were remarkably similar (with perhaps diazepine being insignificantly better at reducing sleep latency) and not additive.[67] Picrotoxin (GABAA antagonist) reversed the benefits on sleep with Ashwagandha, and Muscimol (GABAA agonist) potentiated these benefits on sleep.[67]

Sedation is a common side-effect in some studies when overdose on, actually. One study on aphrodisia found mice given 3g/kg bodyweight had less copulation (despite Ashwagandha being an aphrodisiac) due to over-sedation[68] and a study on Obsessive-Compulsive Disorder had to disregard the highest dose group (100mg/kg) as that dose, despite showing benefit in symptoms, had a great reduction in motor recruitment.[64]

A lack of efficacy of oral Ayurveda has been observed twice in Geriatric populations (whereas the practise of Yoga was able to benefit), but the oral Ayurveda preparation is highly confounded.[69][70]


Edit7. Interactions with Sexuality

7.1. Libido

Ashwagandha is sometimes used as an aphrodisiac, which may be vicariously through its 'adaptogenic' stress reduction (as chronic stress induces sexual dysfunction). One study using a moderate dose in mice (25-50mg/kg bodyweight for 21 days) noted both reductions in stress and decreases in the reductions in sexual activity induced by chronic stress; in a relatively dose-dependent manner.[71] Another study using 3g/kg in mice daily did note reductions in libido, hypothesized to be secondary to sedative effects of Ashwagandha and the larger dose used.[68]

7.2. Seminal Interactions

When 5g of Withania Somnifera root powder is supplemented into otherwise infertile men, all measured seminal parameters (motility, anti-oxidation status, count, concentration, and volume) increase, although not to the levels of the fertile control group.[72] All nutrient counts, such as Vitamin C and fructose, also increase.[72]

A mechanisms behind this pro-seminal effect may be protection from oxidative-induced damage.[73]

7.3. Erections

One human study has been conducted on 'psychogenic erectile dysfunction' (lack of erections due to anxiety and fear of failure) in persons with DSM-IV confirmed Male Erectile Disorder Psychogenic type, and 2g of Ashwagandha root extract taken with meals for 60 days was ineffective in treating this condition.[74] Ashwagandha was associated with significant benefit on all measured parameters (International Index of Erectile Dysfunction), but placebo group matched this benefit.[74]


Edit8. Interactions with Hormones

8.1. Testosterone

There is little to no evidence for usage of Ashwagandha as a testosterone boosting compound in healthy men, only infertile.[72] This aforementioned study used 5g of basic Ashwagandha root powder daily for 6 months and found increases in testosterone in the three tested infertile groups (Asthenozoospermic rose to 121% of baseline, Oligozoospermic to 140% of baseline, and Normozoospermic to 114% of baseline) yet no group surpassed the fertile control groups testosterone level, although normozoospermic was insignificantly different after the end of the trial.[72] A slight increase in testosterone was seen in non-diabetic rats used as a control, alongside a much larger spike in progesterone.[75]

Preliminary evidence that Ashwagandha can normalize reduced testosterone levels in men, but no evidence looking at elevating testosterone beyond baseline levels in healthy individuals

8.2. Luteinizing Hormone

The one study to note LH levels in infertile men noted an increase and a trend towards normalization when compared to fertile men.[72] A study in diabetic rats who had two control groups (non-intervention, Ashwagandha intervention) found LH spikes about three-fold higher with 6.25% Ashwagandha (as assessed on a weight basis of food intake) from 0.2mIU/mL to 0.6mIU/mL after four weeks.[75]

8.3. Follicle-Stimulating Hormone

The one study to note FSH levels noted a decline in tested infertile men, signalling a trend to normalization when compared to the fertile control.[72] These effects have been noted in diabetic mice, and a slight decrease is also seen in control mice with no health complications.[75]

8.4. Thyroid and Thyroid Hormones

In animals, Ashwagandha has been shown to increase circulating T4 levels with no influence on T3 (at 1.4g/kg root extract daily in mice for 20 days[76]) and another study noted both hormones (T3 and T4) increased under the same protocol.[77] The latter study was conducted in male mice, and tested females showed different results; when female mice were tested in isolation,[76] the same increase in hepatic anti-oxidant enzymes (catalase up by 12%) and decrease in lipid peroxidation (34%) was seen, and increased T4 (lesser active thyroid hormone) by approximately 60% without significantly influencing T3 (more active hormone).[76] Ashwagandha has also been investigated as a combination with Guggulsterone gum and Bauhinia Bark (from Bauhinia Purpurea)[78] and appears to be well-tolerated; and a rise in T3 was recorded with this blend[78] possibly due to the Bauhinia.[76]

Beyond that, Ashwagandha possibly has benefit as an adjunct therapy. While Metformin administration can alleviate many effects of experimentally induced type II diabetes, it further reduces circulating T4 levels; Ashwagandha administration at 1.4g/kg ameliorated these adverse changes.[79]

At least one human case study has noted a medically relevant case of hyperthyroidism after usage of a supplement containing Ashwagandha.[80]

Seems to have the ability to stimulate T4 production at the level of the thyroid, but there may be a gender difference in regards to T3 where men can produce more in response to Ashwagandha than women; more studies would be needed for conclusison


Edit9. Hepatic (Liver) Interactions

9.1. Lipid Metabolism

Ashwagandha has been associated with a decrease in circulating cholesterol levels and increased fecal cholesterol excretion in rats, but is confounded with the inclusion of other herbs.[81] It has, however, been noted to do these same effects in isolation.[82]

In a research model of type I diabetes (alloxan-induced), Ashwagandha was able to attenuate adverse changes in LDL, HDL, total cholesterol, and triglycerides to a comparable potency at 200mg/kg as glibenclamide (anti-diabetic drug) dosed at 0.6mg/kg.[83]

In diabetic animals, both the root and leaf of Ashwagandha is also able to decrease circulating liver enzymes at 200mg/kg by 45% (AST and ALT), 31% (ACP) and 16% (ALP).[83]

9.2. Oxidation

Bioaccumulation of cadmium, a hepatotoxic mineral (in excess), has been reduced and the oxidative damage attenuated with herbal adaptogens (of which includes ashwagandha) at low (0.1% of the diet) dosages.[84] Ashwagandha in isolation appears to be able to prevent this toxicity as well.[85]

9.3. Neural

Via the liver, Ashwagandha has been implicated in reversing the pathology of Alzheimer's Disease;[86] more can be read in the Neurology section.


Edit10. Interactions with Carbohydrate Metabolism

10.1. Blood glucose

In a model of type I diabetes (mice injected with streptocozin), Withania Somnifera at 6.25% of the diet may raise fasting blood glucose slightly but significantly.[75]

10.2. Symptoms of Diabetes

One study in rats noted that 6.25% Ashwagandha (on a food weight basis) could attenuate the adverse changes in lutenizing hormone and follicle-stimulating hormone associated with diabetes.[87] No effects were seen on estrogen and progresterone (despite the latter dropping in the experimental group of diabetes) and testosterone changes were not related to the state of diabetes.[88]

Doses of Ashwagandha (100-200mg/kg) have been shown to reduce adverse changes to glucose metabolism after oral ingestion in rats.[83] The higher dose of 200mg/kg was as effective as 0.6mg/kg glibenclamide (anti-diabetic drug) at reducing blood glucose and HbA1c (to near control levels, although not completely) and increasing hepatic liver glycogen and hemoglobin levels.[83] A decrease in glucose-6-phosphatase activity is also seen in the livers of diabetic animals treated with Ashwagandha, to a similar potency to glibenclamide.[83]


Edit11. Nutrient-Nutrient Interactions

11.1. Perment

Perment is a poly-Ayurvedic formula consisting of equal parts (125mg each) of four herbs; Ashwagandha, Clitoria Ternatea, Bacopa Monnieri, and Asparagus Racemosus. It is apparently used clinically for its anti-depressive and anxiolytic effects, and is effective in rat models of chronic unpredictable manageable stress.[89] The combination of the four herbs shows synergism in this regard, but whether synergism exists between all four or just 2-3 herbs is not demonstrated.[89]


Edit12. Safety and Toxicity

12.1. General

The acute LD50 for Ashwagandha extract (2% pure alkaloids) was found to be 465mg/kg in rats and 432mg/kg in mice.[90][16] Whereas other studies using alcohol extracts of Ashwagandha found LD50 values around 1750+/-41mg/kg, 1076 +/- 78 mg/kg and 1564 +/- 92 mg/kg for Ashwagandha, sitoindosides VII and VIII, and withaferin-A respectively.[16][91] In vitro results suggest no toxicity to human blood cells (erythrocytes)[92]

In a subchronic toxicity study using a 10:1 ratio of Panax Ginseng to Ashwagandha taken at 8.50mg/kg, 12.75mg/kg, and 17.00mg/kg bodyweight in rats (4, 6, and 8 times the therapeutic dose) noted that despite increased food intake (70-80% in experimental, 41% in control) there was no abnormal serum parameter indicative of toxicological signs; liver weight increased, but it was uncertain as to whether this was due to the intervention per se or the increased food intake observed. An increase in haematopoesis was seen 1.7-1.9 gm% which led to an increase of 2-2.1million/cumm in RBC count.[93]

12.2. Case studies

At least one confirmed case has established causation with ashwagandha at 5g oral ingestion daily for 10 days (a treatment dosage for libido) caused a burning/itching sensation on the penis mucous membrane, and slight discoloration and reddening of the head and prepuce.[94]

References

  1. Dhuley JN. Adaptogenic and cardioprotective action of ashwagandha in rats and frogs. J Ethnopharmacol. (2000)
  2. Widodo N, et al. Selective killing of cancer cells by Ashwagandha leaf extract and its component Withanone involves ROS signaling. PLoS One. (2010)
  3. Widodo N, et al. Selective killing of cancer cells by leaf extract of Ashwagandha: components, activity and pathway analyses. Cancer Lett. (2008)
  4. Kulkarni SK, Dhir A. Withania somnifera: an Indian ginseng. Prog Neuropsychopharmacol Biol Psychiatry. (2008)
  5. Deocaris CC, et al. Merger of ayurveda and tissue culture-based functional genomics: inspirations from systems biology. J Transl Med. (2008)
  6. Modak M, et al. Indian herbs and herbal drugs used for the treatment of diabetes. J Clin Biochem Nutr. (2007)
  7. Phytochemical variability in commercial herbal products and preparations of Withania somnifera (Ashwagandha)
  8. Misra L, et al. Withanolides from Withania somnifera roots. Phytochemistry. (2008)
  9. Chen LX, He H, Qiu F. Natural withanolides: an overview. Nat Prod Rep. (2011)
  10. Murthy HN, et al. Establishment of Withania somnifera hairy root cultures for the production of withanolide A. J Integr Plant Biol. (2008)
  11. Chaurasiya ND, et al. Analysis of withanolides in root and leaf of Withania somnifera by HPLC with photodiode array and evaporative light scattering detection. Phytochem Anal. (2008)
  12. Withanolide C, A chlorinated withanolide from Withania somnifera
  13. Zhao J, et al. Withanolide derivatives from the roots of Withania somnifera and their neurite outgrowth activities. Chem Pharm Bull (Tokyo). (2002)
  14. Tong X, Zhang H, Timmermann BN. Chlorinated Withanolides from Withania somnifera. Phytochem Lett. (2011)
  15. Bhattacharya SK, Satyan KS, Ghosal S. Antioxidant activity of glycowithanolides from Withania somnifera. Indian J Exp Biol. (1997)
  16. Mishra LC, Singh BB, Dagenais S. Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev. (2000)
  17. Subbaraju GV, et al. Ashwagandhanolide, a bioactive dimeric thiowithanolide isolated from the roots of Withania somnifera. J Nat Prod. (2006)
  18. Withanolides from Withania somnifera roots
  19. Alam N, et al. High catechin concentrations detected in Withania somnifera (ashwagandha) by high performance liquid chromatography analysis. BMC Complement Altern Med. (2011)
  20. Srivastava P, et al. Simultaneous quantification of withanolides in Withania somnifera by a validated high-performance thin-layer chromatographic method. J AOAC Int. (2008)
  21. Matsuda H, et al. Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera DUNAL. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorg Med Chem. (2001)
  22. Bhat J, et al. In vivo enhancement of natural killer cell activity through tea fortified with Ayurvedic herbs. Phytother Res. (2010)
  23. Mikolai J, et al. In vivo effects of Ashwagandha (Withania somnifera) extract on the activation of lymphocytes. J Altern Complement Med. (2009)
  24. Vetvicka V, Vetvickova J. Immune enhancing effects of WB365, a novel combination of Ashwagandha (Withania somnifera) and Maitake (Grifola frondosa) extracts. N Am J Med Sci. (2011)
  25. Widodo N, et al. Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin Cancer Res. (2007)
  26. Widodo N, et al. Deceleration of senescence in normal human fibroblasts by withanone extracted from ashwagandha leaves. J Gerontol A Biol Sci Med Sci. (2009)
  27. Grover A, et al. Ashwagandha derived withanone targets TPX2-Aurora A complex: computational and experimental evidence to its anticancer activity. PLoS One. (2012)
  28. Zhu Z, et al. Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatology. (2009)
  29. Grover A, et al. Withanone binds to mortalin and abrogates mortalin-p53 complex: computational and experimental evidence. Int J Biochem Cell Biol. (2012)
  30. Wadhwa R, et al. Selective toxicity of MKT-077 to cancer cells is mediated by its binding to the hsp70 family protein mot-2 and reactivation of p53 function. Cancer Res. (2000)
  31. p21Waf1/Cip1 Plays a Critical Role in Modulating Senescence Through Changes of DNA Methylation
  32. Withania somnifera reverses Alzheimer’s disease pathology by enhancing low-density lipoprotein receptor-related protein in liver
  33. Zlokovic BV, et al. Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer's amyloid β-peptide elimination from the brain. J Neurochem. (2010)
  34. Sagare A, et al. Clearance of amyloid-beta by circulating lipoprotein receptors. Nat Med. (2007)
  35. Deane R, et al. RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med. (2003)
  36. Withanoside IV and its active metabolite, sominone, attenuate Aβ(25–35)-induced neurodegeneration
  37. Choudhary MI, et al. Cholinesterase inhibiting withanolides from Withania somnifera. Chem Pharm Bull (Tokyo). (2004)
  38. Grover A, et al. Computational evidence to inhibition of human acetyl cholinesterase by withanolide a for Alzheimer treatment. J Biomol Struct Dyn. (2012)
  39. Schliebs R, et al. Systemic administration of defined extracts from Withania somnifera (Indian Ginseng) and Shilajit differentially affects cholinergic but not glutamatergic and GABAergic markers in rat brain. Neurochem Int. (1997)
  40. Yadav CS, et al. Propoxur-induced acetylcholine esterase inhibition and impairment of cognitive function: attenuation by Withania somnifera. Indian J Biochem Biophys. (2010)
  41. Ali SA, Meitei KV. Withania somnifera root extracts induce skin darkening in wall lizard melanophores via stimulation of cholinergic receptors. Nat Prod Res. (2011)
  42. Soman S, et al. Oxidative Stress Induced NMDA Receptor Alteration Leads to Spatial Memory Deficits in Temporal Lobe Epilepsy: Ameliorative Effects of Withania somnifera and Withanolide A. Neurochem Res. (2012)
  43. Kataria H, et al. Water extract from the leaves of Withania somnifera protect RA differentiated C6 and IMR-32 cells against glutamate-induced excitotoxicity. PLoS One. (2012)
  44. Naidu PS, Singh A, Kulkarni SK. Effect of Withania somnifera root extract on reserpine-induced orofacial dyskinesia and cognitive dysfunction. Phytother Res. (2006)
  45. Naidu PS, Singh A, Kulkarni SK. Effect of Withania somnifera root extract on haloperidol-induced orofacial dyskinesia: possible mechanisms of action. J Med Food. (2003)
  46. RajaSankar S, et al. Withania somnifera root extract improves catecholamines and physiological abnormalities seen in a Parkinson's disease model mouse. J Ethnopharmacol. (2009)
  47. Rajasankar S, Manivasagam T, Surendran S. Ashwagandha leaf extract: a potential agent in treating oxidative damage and physiological abnormalities seen in a mouse model of Parkinson's disease. Neurosci Lett. (2009)
  48. Kumar P, Kumar A. Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease. J Med Food. (2009)
  49. Kasture S, et al. Withania somnifera prevents morphine withdrawal-induced decrease in spine density in nucleus accumbens shell of rats: a confocal laser scanning microscopy study. Neurotox Res. (2009)
  50. Spiga S, et al. Morphine withdrawal-induced morphological changes in the nucleus accumbens. Eur J Neurosci. (2005)
  51. Konar A, et al. Protective role of Ashwagandha leaf extract and its component withanone on scopolamine-induced changes in the brain and brain-derived cells. PLoS One. (2011)
  52. Velmurugan K, et al. Synergistic induction of heme oxygenase-1 by the components of the antioxidant supplement Protandim. Free Radic Biol Med. (2009)
  53. Priyandoko D, et al. Ashwagandha leaf derived withanone protects normal human cells against the toxicity of methoxyacetic acid, a major industrial metabolite. PLoS One. (2011)
  54. Kuboyama T, Tohda C, Komatsu K. Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration. Eur J Neurosci. (2006)
  55. Tohda C, Kuboyama T, Komatsu K. Dendrite extension by methanol extract of Ashwagandha (roots of Withania somnifera) in SK-N-SH cells. Neuroreport. (2000)
  56. Kuboyama T, et al. Axon- or dendrite-predominant outgrowth induced by constituents from Ashwagandha. Neuroreport. (2002)
  57. Tohda C, Kuboyama T, Komatsu K. Search for natural products related to regeneration of the neuronal network. Neurosignals. (2005)
  58. Bhattacharya SK, et al. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine. (2000)
  59. Gupta GL, Rana AC. Effect of Withania somnifera Dunal in ethanol-induced anxiolysis and withdrawal anxiety in rats. Indian J Exp Biol. (2008)
  60. Gupta GL, Rana AC. Protective effect of Withania somnifera dunal root extract against protracted social isolation induced behavior in rats. Indian J Physiol Pharmacol. (2007)
  61. A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study
  62. A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study
  63. A standardized Withania somnifera extract significantly reduces stress-related parameters in chronically stressed humans: a double-blind, randomized, placebo-controlled study
  64. Kaurav BP, et al. Influence of Withania somnifera on obsessive compulsive disorder in mice. Asian Pac J Trop Med. (2012)
  65. Joel D. Current animal models of obsessive compulsive disorder: a critical review. Prog Neuropsychopharmacol Biol Psychiatry. (2006)
  66. Kumar A, Kalonia H. Protective effect of Withania somnifera Dunal on the behavioral and biochemical alterations in sleep-disturbed mice (Grid over water suspended method). Indian J Exp Biol. (2007)
  67. Kumar A, Kalonia H. Effect of Withania somnifera on Sleep-Wake Cycle in Sleep-Disturbed Rats: Possible GABAergic Mechanism. Indian J Pharm Sci. (2008)
  68. Ilayperuma I, Ratnasooriya WD, Weerasooriya TR. Effect of Withania somnifera root extract on the sexual behaviour of male rats. Asian J Androl. (2002)
  69. Krishnamurthy MN, Telles S. Assessing depression following two ancient Indian interventions: effects of yoga and ayurveda on older adults in a residential home. J Gerontol Nurs. (2007)
  70. Manjunath NK, Telles S. Influence of Yoga and Ayurveda on self-rated sleep in a geriatric population. Indian J Med Res. (2005)
  71. Bhattacharya SK, Muruganandam AV. Adaptogenic activity of Withania somnifera: an experimental study using a rat model of chronic stress. Pharmacol Biochem Behav. (2003)
  72. Ahmad MK, et al. Withania somnifera improves semen quality by regulating reproductive hormone levels and oxidative stress in seminal plasma of infertile males. Fertil Steril. (2010)
  73. Shukla KK, et al. Withania somnifera improves semen quality by combating oxidative stress and cell death and improving essential metal concentrations. Reprod Biomed Online. (2011)
  74. Mamidi P, Thakar AB. Efficacy of Ashwagandha (Withania somnifera Dunal. Linn.) in the management of psychogenic erectile dysfunction. Ayu. (2011)
  75. Effect of withania somnifera on levels of sex hormones in the diabetic male rats
  76. Panda S, Kar A. Withania somnifera and Bauhinia purpurea in the regulation of circulating thyroid hormone concentrations in female mice. J Ethnopharmacol. (1999)
  77. Panda S, Kar A. Changes in thyroid hormone concentrations after administration of ashwagandha root extract to adult male mice. J Pharm Pharmacol. (1998)
  78. Combined Effects of Ashwagandha, Guggulu and Bauhinia Extracts in the Regulation of Thyroid Function and on Lipid Peroxidation in Mice
  79. Jatwa R, Kar A. Amelioration of metformin-induced hypothyroidism by Withania somnifera and Bauhinia purpurea extracts in Type 2 diabetic mice. Phytother Res. (2009)
  80. van der Hooft CS, et al. Thyrotoxicosis following the use of ashwagandha. Ned Tijdschr Geneeskd. (2005)
  81. Visavadiya NP, Narasimhacharya AV. Ameliorative effects of herbal combinations in hyperlipidemia. Oxid Med Cell Longev. (2011)
  82. Visavadiya NP, Narasimhacharya AV. Hypocholesteremic and antioxidant effects of Withania somnifera (Dunal) in hypercholesteremic rats. Phytomedicine. (2007)
  83. Udayakumar R, et al. Hypoglycaemic and hypolipidaemic effects of Withania somnifera root and leaf extracts on alloxan-induced diabetic rats. Int J Mol Sci. (2009)
  84. Bharavi K, et al. Prevention of cadmium bioaccumulation by herbal adaptogens. Indian J Pharmacol. (2011)
  85. Bharavi K, et al. Reversal of Cadmium-induced Oxidative Stress in Chicken by Herbal Adaptogens Withania Somnifera and Ocimum Sanctum. Toxicol Int. (2010)
  86. Sehgal N, et al. Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver. Proc Natl Acad Sci U S A. (2012)
  87. Effect of withania somnifera on levels of sex hormones in the diabetic male rats
  88. Effect of withania somnifera on levels of sex hormones in the diabetic male rats
  89. Ramanathan M, Balaji B, Justin A. Behavioural and neurochemical evaluation of Perment an herbal formulation in chronic unpredictable mild stress induced depressive model. Indian J Exp Biol. (2011)
  90. Malhotra CL, et al. Studies on Withania ashwagandha, Kaul. IV. The effect of total alkaloids on the smooth muscles. Indian J Physiol Pharmacol. (1965)
  91. Grandhi A, Mujumdar AM, Patwardhan B. A comparative pharmacological investigation of Ashwagandha and Ginseng. J Ethnopharmacol. (1994)
  92. Owais M, et al. Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine. (2005)
  93. Aphale AA, et al. Subacute toxicity study of the combination of ginseng (Panax ginseng) and ashwagandha (Withania somnifera) in rats: a safety assessment. Indian J Physiol Pharmacol. (1998)
  94. Sehgal VN, Verma P, Bhattacharya SN. Fixed-drug eruption caused by ashwagandha (Withania somnifera): a widely used Ayurvedic drug. Skinmed. (2012)
  95. Andallu B, Radhika B. Hypoglycemic, diuretic and hypocholesterolemic effect of winter cherry (Withania somnifera, Dunal) root. Indian J Exp Biol. (2000)

(Common misspellings for Ashwagandha include ashwaganda, ashwhagandha, ashwaghanda, ashwhaghanda)

(Common phrases used by users for this page include ashwagandha therapeutic dose, ashwagandha sperm quality, ashwagandha powder daily dosage, ashwagandha clinical, ashwaganda for sleep, ashwaganda case study invertility)

(Users who contributed to this page include , )